Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Nature's Research Journal Scientific Reports Proves Noom Coach is Effective in Driving Sustained Weight Loss Across Large Populations

Noom Inc
Posted on: 16 Nov 16

PR Newswire

NEW YORK, Nov. 16, 2016

NEW YORK, Nov. 16, 2016 /PRNewswire/ -- A new study published in Scientific Reports, a research journal from the publisher of Nature, found that Noom's consumer mobile app successfully drove sustained weight loss in 78% of users across a 9-month period. The study was the largest of its kind to demonstrate successful weight loss through using a mobile application.

Logo - http://photos.prnewswire.com/prnh/20161115/439908LOGO

The research, published earlier this week in Nature, examined 35,921 Noom Coach users between October 2012 and April 2014 to understand the app's effectiveness. The analysis demonstrated successful weight loss and maintenance for 78% of users over a 9-month period. In addition, 23% of the population lost over 10% of their bodyweight, and the prevalence of obesity decreased by nearly 30%.

"This study looked at Noom's artificial intelligence in driving weight loss in a large population. Even without human coach support or a structured program, the study proves the incredible efficacy of the application and showed that food logging and weight tracking were significant drivers of successful weight loss,"  states Dr. Andreas Michaelides, Chief Psychology Officer at Noom.

The two-year study also concluded that several behaviors were associated with more successful weight loss and maintenance. Specifically, those who logged their activity regularly experienced greater weight loss. In addition, the data showed that users who logged their food intake regularly (particularly dinner) and weighed themselves more frequently were twice as likely to lose weight and keep it off.

"It is widely accepted that self-monitoring in the form of tracking food intake, physical activity, and weight, is effective at producing weight loss. However, previous studies have focused mostly on traditional paper-based tracking. The results of this study contribute to our understanding of the clinical efficacy of virtual self-monitoring using a mobile application," said Dr. Michaelides.

Noom's mobile application has a proprietary food database with over 700,000 branded and generic foods, along with 3.7 million unique food portions that makes self-monitoring of food intake very easy. Nutritional guidance and tracking is a cornerstone of Noom's mobile app technology and structured behavior change programs. The potential of self-monitoring using an app is more valuable in a real-world setting as it can guide users food choices and provide real-time feedback.

According to the CDC, two-thirds of Americans are overweight or obese. In 2008, the annual healthcare cost of obesity in the US was $147 billion. The additional medical cost in those who are obese is $1,429 higher than healthy individuals. Noom's mobile technology and scalable behavior change programs are designed to address obesity and lifestyle related pre-chronic and chronic conditions.

"This study has demonstrated that mobile technologies like Noom are capable of changing behaviors and delivering meaningful, sustainable weight loss at a large scale. Since the study was completed, we have combined this technology with proprietary, condition-specific programs and human coaches to prevent and reverse the most costly and preventable chronic conditions.  To date, Noom has seen that programs with human coaches are three times more effective at driving lasting behavior change. For employers and payers, this has significant implications for not only reducing obesity prevalence but reducing healthcare costs across the acuity spectrum," noted Saeju Jeong, CEO and co-founder at Noom.  "When Noom started, we only focused on fitness and weight loss.  Now we have programs that address obesity, pre-diabetes, diabetes, pre-hypertension, hypertension and the co-morbidity of diabetes and hypertension.  I can't wait to see what 2017 brings."

To read the full report, Click Here

About Noom, Inc.

Noom Inc., a leader in mobile health coaching, combines the power of technology with the empathy of real human coaches to deliver successful behavior change at scale. Noom's direct-to-consumer weight loss and exercise tracking mobile applications have reached more than 45 million users worldwide. Leveraging the success of their ground-breaking health and fitness programs, Noom developed a behavior change platform to treat chronic and pre-chronic conditions, beginning with the CDC's Diabetes Prevention Program (DPP). On the first day, the CDC began recognizing mobile and online DPP providers, Noom was there. Since then, Noom has expanded its curricula across the acuity spectrum and now features programs for pre-hypertension, hypertension and diabetes management in addition to its flagship weight loss and diabetes prevention programs. Noom has offices in New York City, Seoul and Tokyo.

Related Video

https://vimeo.com/189945335

This content was issued through the press release distribution service at Newswire.com. For more info visit: http://www.newswire.com.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/natures-research-journal-scientific-reports-proves-noom-coach-is-effective-in-driving-sustained-weight-loss-across-large-populations-300363852.html

SOURCE Noom Inc

PR Newswire
www.prnewswire.com

Last updated on: 16/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.